Nanocarriers for anticancer drugs - New trends in nanomedicine

Current Drug Metabolism

Volumn 14, Issue 5, 2013, Pages 547-564

  Drbohlavova, Jana ^a,b   Chomoucka, Jana ^a,b   Adam, Vojtech ^b,c   Ryvolova, Marketa ^b,c   Eckschlager, Tomas ^b   Hubalek, Jaromir ^a,b   Kizek, Rene ^b  

^a BRNO UNIVERSITY OF TECHNOLOGY   (Czech Republic)

^b MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anticancer drugs; Cancer; Cytostatic; Drug carriers; Gene therapy; Nanoparticles; Nanotechnologies; Targeted therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBON NANOTUBE; CISPLATIN; CURCUMIN; DAUNORUBICIN; DENDRIMER; DOCETAXEL; DOXORUBICIN; GELDANAMYCIN; GOLD; HYDROXYAPATITE; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; NANOCARRIER; PACLITAXEL; POLYGLACTIN; QUANTUM DOT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CANCER THERAPY; CARDIOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EXCRETION; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; HYDROGEL; MICELLE; NANOMEDICINE; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PROSTATE CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; SOLUBILITY;

EID: 84881631402     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200211314050005     Document Type: Article

References (220)

1. Giljohann, D.A.; Mirkin, C.A. Drivers of biodiagnostic development. Nature, 2009, 462(7272), 461-464.
2. Mirkin, C.A.; Letsinger, R.L.; Mucic, R.C.; Storhoff, J.J. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature, 1996, 382(6592), 607-609. (Pubitemid 26268949)
3. Mirkin, C.A.; Taton, T.A. Materials chemistry - Semiconductors meet biology. Nature, 2000, 405(6787), 626-627. (Pubitemid 30428633)
4. Rosi, N.L.; Giljohann, D.A.; Thaxton, C.S.; Lytton-Jean, A.K.R.; Han, M.S.; Mirkin, C.A. Oligonucleotide-modified gold nanopar-ticles for intracellular gene regulation. Science, 2006, 312(5776), 1027-1030.
5. Marchal, F.; Pic, E.; Pons, T.; Dubertret, B.; Bolotine, L.; Guillemin, F. Quantum dots in oncological surgery: the future for surgical margin status? Bull. Cancer, 2008, 95(12), 1149-1153.
6. Zheng, G.F.; Patolsky, F.; Cui, Y.; Wang, W.U.; Lieber, C.M. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotechnol., 2005, 23(10), 1294-1301. (Pubitemid 41486858)
7. Huska, D.; Hubalek, J.; Adam, V.; Kizek, R. Miniaturized electrochemical detector as a tool for detection of DNA amplified by PCR. Electrophoresis, 2008, 29(24), 4964-4971.
8. Huska, D.; Hubalek, J.; Adam, V.; Vajtr, D.; Horna, A.; Trnkova, L.; Havel, L.; Kizek, R. Automated nucleic acids isolation using paramagnetic microparticles coupled with electrochemical detection. Talanta, 2009, 79(2), 402-411.
9. Adam, V.; Petrlova, J.; Wang, J.; Eckschlager, T.; Trnkova, L.; Kizek, R. Zeptomole electrochemical detection of metallothione-ins. PLoS One, 2010, 5(7), e11441.
10. Patra, C.R.; Bhattacharya, R.; Mukhopadhyay, D.; Mukherjee, P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv. Drug Deliv. Rev., 2010, 62(3), 346-361.
11. Gu, F.X.; Karnik, R.; Wang, A.Z.; Alexis, F.; Levy-Nissenbaum, E.; Hong, S.; Langer, R.S.; Farokhzad, O.C. Targeted nanoparti-cles for cancer therapy. Nano Today, 2007, 2(3), 14-21.
12. Chomoucka, J.; Drbohlavova, J.; Huska, D.; Adam, V.; Kizek, R.; Hubalek, J. Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res., 2010, 62(2), 144-149.
13. Hu, C.M.J.; Zhang, L.F. Therapeutic Nanoparticles to Combat Cancer Drug Resistance. Curr. Drug Metab., 2009, 10(8), 836-841.
14. Drbohlavova, J.; Adam, V.; Kizek, R.; Hubalek, J. Quantum Dots-Characterization, Preparation and Usage in Biological Systems. Int. J. Mol. Sci., 2009, 10(2), 656-673.
15. Drbohlavova, J.; Hrdy, R.; Adam, V.; Kizek, R.; Schneeweiss, O.; Hubalek, J. Preparation and properties of various magnetic nanoparticles. Sensors, 2009, 9(3), 2352-2362.
16. Palecek, E.; Fojta, M. Magnetic beads as versatile tools for electrochemical DNA and protein biosensing. Talanta, 2007, 74(3), 276-290. (Pubitemid 350192529)
17. Wang, J.Q.; Sui, M.H.; Fan, W.M. Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics. Curr. Drug Metab., 2010, 11(2), 129-141.
18. Adiseshaiah, P.P.; Hall, J.B.; McNeil, S.E. Nanomaterial standards for efficacy and toxicity assessment. Wiley Interdiscip. Rev.-Nanomed. Nanobiotechnol., 2010, 2(1), 99-112.
19. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer, 2005, 5(3), 161-171. (Pubitemid 40314948)
20. Juillerat-Jeanneret, L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today, 2008, 13(23-24), 1099-1106.
21. Cho, K.J.; Wang, X.; Nie, S.M.; Chen, Z.; Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res., 2008, 14(5), 1310-1316. (Pubitemid 351413909)
22. Mishra, B.; Patel, B.B.; Tiwari, S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(1), 9-24.
23. Peer, D.; Karp, J.M.; Hong, S.; FaroKhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol., 2007, 2(12), 751-760. (Pubitemid 350223348)
24. Haley, B.; Frenkel, E. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol.-Semin. Orig. Investig., 2008, 26(1), 57-64.
25. Puri, A.; Loomis, K.; Smith, B.; Lee, J.H.; Yavlovich, A.; Heldman, E.; Blumenthal, R. Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic. Crit. Rev. Ther. Drug Carr. Syst., 2009, 26(6), 523-580.
26. Allen, T.M.; Cullis, P.R. Drug delivery systems: Entering the mainstream. Science, 2004, 303(5665), 1818-1822. (Pubitemid 38374867)
27. LaVan, D.A.; McGuire, T.; Langer, R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol., 2003, 21(10), 1184-1191. (Pubitemid 37186175)
28. Cavalcanti, A.; Shirinzadeh, B.; Freitas, R.A.; Hogg, T. Nanorobot architecture for medical target identification. Nanotechnology, 2008, 19(1), 15.
29. Torchilin, V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release, 2001, 73(2-3), 137-172. (Pubitemid 32544594)
30. Stolnik, S.; Daudali, B.; Arien, A.; Whetstone, J.; Heald, C.R.; Garnett, M.C.; Davis, S.S.; Illum, L. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of polox-amer 407 on the biological fate of model colloidal drug carriers. Biochim. Biophys. Acta-Biomembr., 2001, 1514(2), 261-279. (Pubitemid 32831014)
31. Yallapu, M.M.; Jaggi, M.; Chauhan, S.C. Design and engineering of nanogels for cancer treatment. Drug Discov. Today, 2011, 16(9-10), 457-463.
32. Watanabe, K.; Tsuchiya, Y.; Kawaguchi, Y.; Sawada, S.i.; Ayame, H.; Akiyoshi, K.; Tsubata, T. The use of cationic nanogels to deliver proteins to myeloma cells and primary T lymphocytes that poorly express heparan sulfate. Biomaterials, 32(25), 5900-5905.
33. Wei, H.; Cheng, S.X.; Zhang, X.Z.; Zhuo, R.X. Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers. Prog. Polym. Sci., 2009, 34(9), 893-910.
34. Wong, H.L.; Bendayan, R.; Rauth, A.M.; Li, Y.; Wu, X.Y. Chemotherapy with anticancer drugs encapsulated in solid lipid nanopar-ticles. Adv. Drug Deliv. Rev., 2007, 59(6), 491-504. (Pubitemid 47259227)
35. Gao, F.P.; Li, L.; Zhang, H.Z.; Yang, W.Z.; Chen, H.L.; Zhou, J.; Zhou, Z.M.; Wang, Y.S.; Cai, Y.Y.; Li, X.M.; Liu, L.R.; Zhang, Q.Q. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: In vitro and in vivo studies. Int. J. Pharm., 2010, 392(1-2), 254-260.
36. Yallapu, M.M.; Jaggi, M.; Chauhan, S.C. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloid Surf. B-Biointerfaces, 2010, 79(1), 113-125.
37. Goodrich, G.P.; Bao, L.L.; Gill-Sharp, K.; Sang, K.L.; Wang, J.; Payne, J.D. Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods. J. Biomed. Opt., 2010, 15(1), 8.
38. Chen, J.Y.; Glaus, C.; Laforest, R.; Zhang, Q.; Yang, M.X.; Gidding, M.; Welch, M.J.; Xia, Y.N. Gold Nanocages as Photothermal Transducers for Cancer Treatment. Small, 2010, 6(7), 811-817.
39. Zhang, J.Z. Biomedical Applications of Shape-Controlled Plas-monic Nanostructures: A Case Study of Hollow Gold Nanospheres for Photothermal Ablation Therapy of Cancer. J. Phys. Chem. Lett., 2010, 1(4), 686-695.
40. Arnida; Malugin, A.; Ghandehari, H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J. Appl. Toxicol., 2010, 30(3), 212-217.
41. Asadishad, B.; Vosoughi, M.; Alamzadeh, I.; Tavakoli, A. Synthesis of Folate-Modified, Polyethylene Glycol-Functionalized Gold Nanoparticles for Targeted Drug Delivery. J. Dispersion Sci. Tech-nol., 2010, 31(4), 492-500.
42. Cuong, N.V.; Hsieh, M.F. Recent Advances in Pharmacokinetics of Polymeric Excipients Used in Nanosized Anti-Cancer Drugs. Curr. Drug Metab., 2009, 10(8), 842-850.
43. Oishi, M.; Nagasaki, Y. Stimuli-responsive smart nanogels for cancer diagnostics and therapy. Nanomedicine, 2010, 5(3), 451-468.
44. Lia, L.; Zheng, J.J.; Jiang, S.M.; Huang, K.H. Preparation, phys-icochemical characterization and cytotoxicity in vitro of gemcit-abine-loaded PEG-PDLLA nanovesicles. World J. Gastroenterol., 2010, 16(8), 1008-1013.
45. Zhu, J.D.; Zhou, Z.C.; Yang, C.H.; Kong, D.L.; Wan, Y.; Wang, Z. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers. J. Biomed. Mater. Res. Part A, 2011, 97A(4), 498-508.
46. Cheng, F.Y.; Su, C.H.; Wu, P.C.; Yeh, C.S. Multifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivo. Chem. Commun., 2010, 46(18), 3167-3169.
47. Koppolu, B.; Rahimi, M.; Nattama, S.; Wadajkar, A.; Nguyen, K.T. Development of multiple-layer polymeric particles for targeted and controlled drug delivery. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(2), 355-361.
48. Dinarvand, R.; Sepehri, N.; Manoochehri, S.; Rouhani, H.; Atyabi, F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int. J. Nanomed., 2011, 6(877-895.
49. Jain, A.K.; Das, M.; Swarnakar, N.K.; Jain, S. Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics. Crit. Rev. Ther. Drug Carr. Syst., 2011, 28(1), 1-45.
50. Pan, J.; Liu, Y.T.; Feng, S.S. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine, 2010, 5(3), 347-360.
51. Cruz, L.J.; Tacken, P.J.; Bonetto, F.; Buschow, S.I.; Croes, H.J.; Wijers, M.; de Vries, I.J.; Figdor, C.G. Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells. Mol. Pharm., 2011, 8(2), 520-531.
52. Garcia, M.E.; Baker, L.A.; Crooks, R.M. Preparation and characterization of dendrimer-gold colloid nanocomposites. Anal. Chem., 1999, 71(1), 256-258. (Pubitemid 29029535)
53. Wells, M.; Crooks, R.M. Interactions between organized, surface-confined monolayers and vapor-phase probe molecules.10. Preparation and properties of chemically sensitive dendrimer surfaces. J. Am. Chem. Soc., 1996, 118(16), 3988-3989. (Pubitemid 26164900)
54. Bae, Y.; Fukushima, S.; Harada, A.; Kataoka, K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change. Angew. Chem.-Int. Edit., 2003, 42(38), 4640-4643. (Pubitemid 37271305)
55. Taratula, O.; Garbuzenko, O.B.; Kirkpatrick, P.; Pandya, I.; Savla, R.; Pozharov, V.P.; He, H.X.; Minko, T. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J. Control. Release, 2009, 140(3), 284-293.
56. Cui, D.M.; Xu, Q.W.; Gu, S.X.; Shi, J.L.; Che, X.M. PAMAM-drug complex for delivering anticancer drug across blood-brain barrier in-vitro and in-vivo. Afr. J. Pharm. Pharmacol., 2009, 3(5), 227-233.
57. Zhu, S.J.; Hong, M.H.; Tang, G.T.; Qian, L.L.; Lin, J.Y.; Jiang, Y.Y.; Pei, Y.Y. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: The effects of PEGylation degree and drug conjugation style. Biomaterials, 2010, 31(6), 1360-1371.
58. Shen, M.W.; Sun, K.; Shi, X.Y. Hydroxylated Dendrimer-Stabilized Gold and Silver Nanoparticles: Spontaneous Formation, Characterization, and Surface Properties. Curr. Nanosci., 2010, 6(3), 307-314.
59. Myc, A.; Kukowska-Latallo, J.; Cao, P.; Swanson, B.; Battista, J.; Dunham, T.; Baker, J.R. Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo. Anti-Cancer Drugs, 2010, 21(2), 186-192.
60. Neerman, M.F. The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukernic drug 6-mercaptopurine. AntiCancer Drugs, 2007, 18(7), 839-842. (Pubitemid 46975973)
61. Howell, B.A.; Fan, D.; Rakesh, L. Thermal decomposition of a generation 4.5 PAMAM dendrimer platinum drug conjugate. J. Therm. Anal. Calorim., 2006, 85(1), 17-20. (Pubitemid 44128095)
62. NiculescuDuvaz, I.; Springer, C.J. Antibody-directed enzyme prodrug therapy (ADEPT): A review. Adv. Drug Deliv. Rev., 1997, 26(2-3), 151-172. (Pubitemid 27289531)
63. Syrigos, K.N.; Epenetos, A.A. Antibody directed enzyme prodrug therapy (ADEPT): A review of the experimental and clinical considerations. Anticancer Res., 1999, 19(1A), 605-613. (Pubitemid 29168301)
64. Manabe, T.; Okino, H.; Maeyama, R.; Mizumoto, K.; Nagai, E.; Tanaka, M.; Matsuda, T. Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems. J. Control. Release, 2004, 100(3), 317-330. (Pubitemid 39572915)
65. Ziaie, B.; Baldi, A.; Lei, M.; Gu, Y.D.; Siegel, R.A. Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. Adv. Drug Deliv. Rev., 2004, 56(2), 145-172. (Pubitemid 38114928)
66. Alvarez-Lorenzo, C.; Concheiro, A. Intelligent Drug Delivery Systems: Polymeric Micelles and Hydrogels. Mini-Rev. Med. Chem., 2008, 8(11), 1065-1074.
67. Bergmann, N.M.; Peppas, N.A. Configurational Biomimetic Imprinting for Protein Recognition: Structural Characteristics of Recognitive Hydrogels. Ind. Eng. Chem. Res., 2008, 47(23), 9099-9107.
68. Byrne, M.E.; Salian, V. Molecular imprinting within hydrogels II: Progress and analysis of the field. Int. J. Pharm., 2008, 364(2), 188-212.
69. Kryscio, D.R.; Peppas, N.A. Mimicking Biological Delivery Through Feed back-Controlled Drug Release Systems Based on Molecular Imprinting. Aiche J., 2009, 55(6), 1311-1324.
70. Tov, O.Y.; Luvitch, S.; Bianco-Peled, H. Molecularly imprinted hydrogel displaying reduced non-specific binding and improved protein recognition. J. Sep. Sci., 2010, 33(11), 1673-1681.
71. Byrne, M.E.; Park, K.; Peppas, N.A. Molecular imprinting within hydrogels. Adv. Drug Deliv. Rev., 2002, 54(1), 149-161. (Pubitemid 34075318)
72. Miyata, T.; Uragami, T.; Nakamae, K. Biomolecule-sensitive hydrogels. Adv. Drug Deliv. Rev., 2002, 54(1), 79-98. (Pubitemid 34075315)
73. Peppas, N.A.; Keys, K.B.; Torres-Lugo, M.; Lowman, A.M. Poly(ethylene glycol)-containing hydrogels in drug delivery. J. Control. Release, 1999, 62(1-2), 81-87. (Pubitemid 29486486)
74. Rosler, A.; Vandermeulen, G.W.M.; Klok, H.A. Advanced drug delivery devices via self-assembly of amphiphilic block copoly-mers. Adv. Drug Deliv. Rev., 2001, 53(1), 95-108. (Pubitemid 33152835)
75. Cunliffe, D.; Kirby, A.; Alexander, C. Molecularly imprinted drug delivery systems. Adv. Drug Deliv. Rev., 2005, 57(12), 1836-1853. (Pubitemid 41643052)
76. Sellergren, B.; Allender, C.J. Molecularly imprinted polymers: A bridge to advanced drug delivery. Adv. Drug Deliv. Rev., 2005, 57(12), 1733-1741. (Pubitemid 41643047)
77. Schillemans, J.P.; van Nostrum, C.F. Molecularly imprinted polymer particles: synthetic receptors for future medicine. Nanomedi-cine, 2006, 1(4), 437-447.
78. Alvarez-Lorenzo, C.; Concheiro, A. Molecularly imprinted polymers for drug delivery. J. Chromatogr. B, 2004, 804(1), 231-245. (Pubitemid 38469889)
79. Zhao, L.L.; Zhu, L.J.; Liu, F.Y.; Liu, C.Y.; Shan, D.; Wang, Q.; Zhang, C.L.; Li, J.L.; Liu, J.G.; Qu, X.Z.; Yang, Z.Z. pH triggered injectable amphiphilic hydrogel containing doxorubicin and pacli-taxel. Int. J. Pharm., 2011, 410(1-2), 83-91.
80. Weyland, M.; Manero, F.; Paillard, A.; Gree, D.; Viault, G.; Jarnet, D.; Menei, P.; Juin, P.; Chourpa, I.; Benoit, J.P.; Gree, R.; Garcion, E. Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1. J. Control. Release, 2011, 151(1), 74-82.
81. Hu, Y.R.; Li, K.; Wang, L.; Yin, S.S.; Zhang, Z.Z.; Zhang, Y. Pegylated immuno-lipopolyplexes: A novel non-viral gene delivery system for liver cancer therapy. J. Control. Release, 2010, 144(1), 75-81.
82. Malam, Y.; Loizidou, M.; Seifalian, A.M. Liposomes and nanopar-ticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci., 2009, 30(11), 592-599.
83. Davis, M.E.; Chen, Z.; Shin, D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov., 2008, 7(9), 771-782.
84. Ying, X.; Wen, H.; Lu, W.L.; Du, J.; Guo, J.; Tian, W.; Men, Y.; Zhang, Y.; Li, R.J.; Yang, T.Y.; Shang, D.W.; Lou, J.N.; Zhang, L.R.; Zhang, Q. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J. Control. Release, 2010, 141(2), 183-192.
85. Epperly, M.W.; Lai, S.Y.; Kanai, A.J.; Mason, N.; Lopresi, B.; Dixon, T.; Franicola, D.; Niu, Y.Y.; Wilson, W.R.; Greenberger, J.S. Effectiveness of Combined Modality Radiotherapy of Ortho-topic Human Squamous Cell Carcinomas in Nu/Nu Mice Using Cetuximab, Tirapazamine and MnSOD-Plasmid Liposome Gene Therapy. In Vivo, 2010, 24(1), 1-8.
86. Hayashi, S.; Mizuno, M.; Yoshida, J.; Nakao, A. Effect of sonopo-ration on cationic liposome-mediated IFN beta gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther., 2009, 16(8), 638-643.
87. Kajiwara, E.; Kawano, K.; Hattori, Y.; Fukushima, M.; Hayashi, K.; Maitani, Y. Long-circulating liposome-encapsulated ganci-clovir enhances the efficacy of HSV-TK suicide gene therapy. J. Control. Release, 2007, 120(1-2), 104-110. (Pubitemid 46874624)
88. Nakase, M.; Inui, M.; Okumura, K.; Kamei, T.; Nakamura, S.; Tagawa, T. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome. Mol. Cancer Ther., 2005, 4(4), 625-631. (Pubitemid 40601844)
89. Al-Jamal, W.T.; Al-Jamal, K.T.; Bomans, P.H.; Frederik, P.M.; Kostarelos, K. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small, 2008, 4(9), 1406-1415.
90. Il Kang, D.; Kang, H.K.; Gwak, H.S.; Han, H.K.; Lim, S.J. Liposome composition is important for retention of liposomal rho-damine in P-glycoprotein-overexpressing cancer cells. Drug Deliv., 2009, 16(5), 261-267.
91. Matsui, M.; Shimizu, Y.; Kodera, Y.; Kondo, E.; Ikehara, Y.; Nakanishi, H. Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer. Cancer Sci., 2010, 101(7), 1670-1677.
92. Narayanan, N.K.; Nargi, D.; Randolph, C.; Narayanan, B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer, 2009, 125(1), 1-8.
93. Wenzel, J.; Zeisig, R.; Haider, W.; Habedank, S.; Fichtner, I. Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation. Breast Cancer Res. Treat., 2010, 121(1), 13-22.
94. Chiu, G.N.C.; Wong, M.Y.; Ling, L.U.; Shaikh, I.M.; Tan, K.B.; Chaudhury, A.; Tan, B.J. Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities. Curr. Drug Metab., 2009, 10(8), 861-874.
95. Chen, H.; Ahn, R.; Van den Bossche, J.; Thompson, D.H.; O'Halloran, T.V. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol. Cancer Ther., 2009, 8(7), 1955-1963.
96. Ashley, C.E.; Carnes, E.C.; Phillips, G.K.; Padilla, D.; Durfee, P.N.; Brown, P.A.; Hanna, T.N.; Liu, J.W.; Phillips, B.; Carter, M.B.; Carroll, N.J.; Jiang, X.M.; Dunphy, D.R.; Willman, C.L.; Petsev, D.N.; Evans, D.G.; Parikh, A.N.; Chackerian, B.; Wharton, W.; Peabody, D.S.; Brinker, C.J. The targeted delivery of mul-ticomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater., 2011, 10(5), 389-397.
97. Bedi, D.; Musacchio, T.; Fagbohun, O.A.; Gillespie, J.W.; Deinnocentes, P.; Bird, R.C.; Bookbinder, L.; Torchilin, V.P.; Petrenko, V.A. Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomed.-Nanotechnol. Biol. Med., 2011, 7(3), 315-323.
98. Abu Lila, A.S.; Doi, Y.; Nakamura, K.; Ishida, T.; Kiwada, H. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor. J. Control. Release, 2010, 142(2), 167-173.
99. Maeda, H.; Bharate, G.Y.; Daruwalla, J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm., 2009, 71(3), 409-419.
100. Maeda, H. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects. Bioconjugate Chem., 2010, 21(5), 797-802.
101. Chandran, T.; Katragadda, U.; Teng, Q.; Tan, C. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG). Int. J. Pharm., 2010, 392(1-2), 170-177.
102. Xu, R.Z.; Fisher, M.; Juliano, R.L. Targeted Albumin-Based Nanoparticles for Delivery of Amphipathic Drugs. Bioconjugate Chem., 2011, 22(5), 870-878.
103. Poon, Z.; Lee, J.A.; Huang, S.W.; Prevost, R.J.; Hammond, P.T. Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting. Nanomed.-Nanotechnol. Biol. Med., 2011, 7(2), 201-209.
104. Venkatesan, P.; Puvvada, N.; Dash, R.; Kumar, B.N.P.; Sarkar, D.; Azab, B.; Pathak, A.; Kundu, S.C.; Fisher, P.B.; Mandal, M. The potential of celecoxib-loaded hydroxyapatite-chitosan nanocom-posite for the treatment of colon cancer. Biomaterials, 2011, 32(15), 3794-3806.
105. Wang, K.W.; Zhu, Y.J.; Chen, X.Y.; Zhai, W.Y.; Wang, Q.; Chen, F.; Chang, J.A.; Duan, Y.R. Flower-Like Hierarchically Nanostruc-tured Hydroxyapatite Hollow Spheres: Facile Preparation and Application in Anticancer Drug Cellular Delivery. Chem.-Asian J., 2010, 5(12), 2477-2482.
106. Wang, S.; Chen, K.-J.; Wu, T.-H.; Wang, H.; Lin, W.-Y.; Ohashi, M.; Chiou, P.-Y.; Tseng, H.-R. Photothermal Effects of Su-pramolecularly Assembled Gold Nanoparticles for the Targeted Treatment of Cancer Cells. Angew. Chem.-Int. Edit., 2010, 49(22), 3777-3781.
107. Panyala, N.R.; Pena-Mendez, E.M.; Havel, J. Gold and nano-gold in medicine: overview, toxicology and perspectives. J. Appl. Bio-med., 2009, 7(2), 75-91.
108. Giljohann, D.A.; Seferos, D.S.; Daniel, W.L.; Massich, M.D.; Patel, P.C.; Mirkin, C.A. Gold Nanoparticles for Biology and Medicine. Angew. Chem.-Int. Edit., 2010, 49(19), 3280-3294.
109. Ghosh, P.; Han, G.; De, M.; Kim, C.K.; Rotello, V.M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev., 2008, 60(11), 1307-1315.
110. Bhattacharya, R.; Patra, C.R.; Earl, A.; Wang, S.F.; Katarya, A.; Lu, L.; Kizhakkedathu, J.N.; Yaszemski, M.J.; Greipp, P.R.; Mukhopadhyay, D.; Mukherjee, P. Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomed.-Nanotechnol. Biol. Med., 2007, 3(3), 224-238. (Pubitemid 47332348)
111. Rozenberg, B.A.; Tenne, R. Polymer-assisted fabrication of nanoparticles and nanocomposites. Prog. Polym. Sci., 2008, 33(1), 40-112. (Pubitemid 350266042)
112. Pissuwan, D.; Niidome, T.; Cortie, M.B. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J. Control. Release, 2010, in press, doi:10.1016/j.jconrel.2009.12.006.
113. Chanda, N.; Kan, P.; Watkinson, L.D.; Shukla, R.; Zambre, A.; Carmack, T.L.; Engelbrecht, H.; Lever, J.R.; Katti, K.; Fent, G.M.; Casteel, S.W.; Smith, C.J.; Miller, W.H.; Jurisson, S.; Boote, E.; Robertson, J.D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K.V. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-(AuNP)-Au-198 nanoconstruct in prostate tumor-bearing mice. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(2), 201-209.
114. Huang, C.W.; Hao, Y.W.; Nyagilo, J.; Dave, D.P.; Xu, L.F.; Sun, X.K. Porous Hollow Gold Nanoparticles for Cancer SERS Imaging. J. Nano Res., 2010, 10(137-148.
115. Dickerson, E.B.; Dreaden, E.C.; Huang, X.H.; El-Sayed, I.H.; Chu, H.H.; Pushpanketh, S.; McDonald, J.F.; El-Sayed, M.A. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett., 2008, 269(1), 57-66.
116. Hutter, E.; Boridy, S.; Labrecque, S.; Lalancette-Hebert, M.; Kriz, J.; Winnik, F.M.; Maysinger, D. Microglial Response to Gold Nanoparticles. ACS Nano, 2010, 4(5), 2595-2606.
117. Wang, F.; Wang, Y.C.; Dou, S.; Xiong, M.H.; Sun, T.M.; Wang, J. Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells. ACS Nano, 2011, 5(5), 3679-3692.
118. Dutta, R.K.; Sharma, P.K.; Pandey, A.C. Design and surface modification of potential luminomagnetic nanocarriers for biomedical applications. J. Nanopart. Res., 2010, 12(4), 1211-1219.
119. Sun, C.; Lee, J.S.H.; Zhang, M.Q. Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev., 2008, 60(11), 1252-1265.
120. Plank, C. NANOMEDICINE Silence the target. Nat. Nanotech-nol., 2009, 4(9), 544-545.
121. Muzquiz-Ramos, E.M.; Cortes-Hernandez, D.A.; Escobedo-Bocardo, J. Biomimetic apatite coating on magnetite particles. Mater. Lett., 2010, 64(9), 1117-1119.
122. Zhang, R.Y.; Wu, C.H.; Wang, X.M.; Sun, Q.; Chen, B.A.; Li, X.M.; Gutmann, S.; Lv, G. Enhancement effect of nano Fe3O4 to the drug accumulation of doxorubicin in cancer cells. Mater. Sci. Eng. C-Biomimetic Supramol. Syst., 2009, 29(5), 1697-1701.
123. Dilnawaz, F.; Singh, A.; Mohanty, C.; Sahoo, S.K. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials, 2010, 31(13), 3694-3706.
124. Yang, X.Q.; Hong, H.; Grailer, J.J.; Rowland, I.J.; Javadi, A.; Hurley, S.A.; Xiao, Y.L.; Yang, Y.A.; Zhang, Y.; Nickles, R.; Cai, W.B.; Steeber, D.A.; Gong, S.Q. cRGD-functionalized, DOX-conjugated, and Cu-64-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials, 2011, 32(17), 4151-4160.
125. Rousserie, G.; Sukhanova, A.; Even-Desrumeaux, K.; Fleury, F.; Chames, P.; Baty, D.; Oleinikov, V.; Pluot, M.; Cohen, J.H.M.; Nabiev, I. Semiconductor quantum dots for multiplexed bio-detection on solid-state microarrays. Crit. Rev. Oncol./Hematol., 2010, 74(1), 1-15.
126. Walling, M.A.; Novak, J.A.; Shepard, J.R.E. Quantum Dots for Live Cell and In Vivo Imaging. Int. J. Mol. Sci., 2009, 10(2), 441-491.
127. Galian, R.E.; de la Guardia, M. The use of quantum dots in organic chemistry. Trac-Trends Anal. Chem., 2009, 28(3), 279-291.
128. Azzazy, H.M.E.; Mansour, M.M.H.; Kazinierczak, S.C. From diagnostics to therapy: Prospects of quantum dots. Clin. Biochem., 2007, 40(13-14), 917-927. (Pubitemid 47301793)
129. Li, H.C.; Zhou, Q.F.; Liu, W.; Yan, B.; Zhao, Y.; Jiang, G.B. Progress in the toxicological researches for quantum dots. Sci. China Ser. B-Chem., 2008, 51(5), 393-400. (Pubitemid 351642186)
130. Xing, Y.; Xia, Z.Y.; Rao, J.H. Semiconductor Quantum Dots for Biosensing and In Vivo Imaging. IEEE Trans. Nanobiosci., 2009, 8(1), 4-12.
131. Cai, W.B.; Hsu, A.R.; Li, Z.B.; Chen, X.Y. Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res. Lett., 2007, 2(6), 265-281. (Pubitemid 47139333)
132. Nozik, A.J. Spectroscopy and hot electron relaxation dynamics in semiconductor quantum wells and quantum dots. Annu. Rev. Phys. Chem., 2001, 52(193-231.
133. Murcia, M.J.; Naumann, C.A. Biofunctionalization of Fluorescent Nanoparticles. Wiley-VCH: Weinheim, Germany, 2005.
134. Peng, C.W.; Li, Y. Application of Quantum Dots-Based Biotechnology in Cancer Diagnosis: Current Status and Future Perspectives. J. Nanomater., 2010, Art. No. 676839(11.
135. Bothun, G.D.; Rabideau, A.E.; Stoner, M.A. Hepatoma Cell Uptake of Cationic Multifluorescent Quantum Dot Liposomes. J. Phys. Chem. B, 2009, 113(22), 7725-7728.
136. Biju, V.; Mundayoor, S.; Omkumar, R.V.; Anas, A.; Ishikawa, M. Bioconjugated quantum dots for cancer research: Present status, prospects and remaining issues. Biotechnol. Adv., 2010, 28(2), 199-213.
137. Yuan, Q.; Hein, S.; Misra, R.D.K. New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: Synthesis, characterization and in vitro drug delivery response. Acta Biomater., 2010, 6(2732-2739.
138. Juzenas, P.; Chen, W.; Sun, Y.P.; Coelho, M.A.N.; Generalov, R.; Generalova, N.; Christensen, I.L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev., 2008, 60(15), 1600-1614.
139. Nurunnabi, M.; Cho, K.J.; Choi, J.S.; Huh, K.M.; Lee, Y.k. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials, 2010, 31(5436.
140. Yang, Y.; Song, W.X.; Wang, A.H.; Zhu, P.L.; Fei, J.B.; Li, J.B. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers. Phys. Chem. Chem. Phys., 2010, 12(17), 4418-4422.
141. Zhu, Y.F.; Ikoma, T.; Hanagata, N.; Kaskel, S. Rattle-Type Fe3O4@SiO2 Hollow Mesoporous Spheres as Carriers for Drug Delivery. Small, 2010, 6(3), 471-478.
142. Stevens, E.V.; Carpenter, A.W.; Shin, J.H.; Liu, J.S.; Der, C.J.; Schoenfisch, M.H. Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell Growth. Mol. Pharm., 2010, 7(3), 775-785.
143. Tao, Z.M.; Toms, B.; Goodisman, J.; Asefa, T. Mesoporous Silica Microparticles Enhance the Cytotoxicity of Anticancer Platinum Drugs. ACS Nano, 2010, 4(2), 789-794.
144. Deng, Z.W.; Zhen, Z.P.; Hu, X.X.; Wu, S.L.; Xu, Z.S.; Chu, P.K. Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials, 2011, 32(21), 4976-4986.
145. Yuan, L.; Tang, Q.Q.; Yang, D.; Zhang, J.Z.; Zhang, F.Y.; Hu, J.H. Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery. J. Phys. Chem. C, 2011, 115(20), 9926-9932.
146. Wang, T.T.; Chai, F.; Fu, Q.; Zhang, L.Y.; Liu, H.Y.; Li, L.; Liao, Y.; Su, Z.M.; Wang, C.A.; Duan, B.Y.; Ren, D.X. Uniform hollow mesoporous silica nanocages for drug delivery in vitro and in vivo for liver cancer therapy. J. Mater. Chem., 2011, 21(14), 5299-5306.
147. Liang, F.; Chen, B. A Review on Biomedical Applications of Single-Walled Carbon Nanotubes. Curr. Med. Chem., 2010, 17(1), 10-24.
148. Ghosh, S.; Dutta, S.; Gomes, E.; Carroll, D.; D'Agostino, R.; Olson, J.; Guthold, M.; Gmeiner, W.H. Increased Heating Efficiency and Selective Thermal Ablation of Malignant Tissue with DNA-Encased Multiwalled Carbon Nanotubes. ACS Nano, 2009, 3(9), 2667-2673.
149. Singh, R.; Lillard, J.W. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., 2009, 86(3), 215-223.
150. Qiao, W.L.; Wang, B.C.; Wang, Y.Z.; Yang, L.C.; Zhang, Y.Q.; Shao, P.Y. Cancer Therapy Based on Nanomaterials and Nano-carrier Systems. J. Nanomater., 2010, Art. No. 796303(9.
151. Chaudhuri, P.; Soni, S.; Sengupta, S. Single-walled carbon nano-tube-conjugated chemotherapy exhibits increased therapeutic index in melanoma. Nanotechnology, 2010, 21(2), 11.
152. Liu, J.; Jiang, Z.Z.; Zhang, S.M.; Saltzman, W.M. Poly(omega- pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery. Biomaterials, 2009, 30(29), 5707-5719.
153. Mahmood, M.; Karmakar, A.; Fejleh, A.; Mocan, T.; Iancu, C.; Mocan, L.; Iancu, D.T.; Xu, Y.; Dervishi, E.; Li, Z.R.; Biris, A.R.; Agarwal, R.; Ali, N.; Galanzha, E.I.; Biris, A.S.; Zharov, V.P. Syn-ergistic enhancement of cancer therapy using a combination of carbon nanotubes and anti-tumor drug. Nanomedicine, 2009, 4(8), 883-893.
154. Zhang, X.K.; Meng, L.J.; Lu, Q.G.; Fei, Z.F.; Dyson, P.J. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials, 2009, 30(30), 6041-6047.
155. Wu, W.; Li, R.T.; Bian, X.C.; Zhu, Z.S.; Ding, D.; Li, X.L.; Jia, Z.J.; Jiang, X.Q.; Hu, Y.Q. Covalently Combining Carbon Nano-tubes with Anticancer Agent: Preparation and Antitumor Activity. ACS Nano, 2009, 3(9), 2740-2750.
156. Sahoo, N.G.; Bao, H.Q.; Pan, Y.Z.; Pal, M.; Kakran, M.; Cheng, H.K.F.; Li, L.; Tan, L.P. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem. Commun., 2011, 47(18), 5235-5237.
157. Wani, M.C.; Taylor, H.L.; Wall, M.E.; Coggon, P.; McPhail, A.T. Plant antitumor agents. 6. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus Brevifolia. J. Am. Chem. Soc., 1971, 93(9), 2325-2357.
158. Spratlin, J.; Sawyer, M.B. Pharmacogenetics of paclitaxel metabolism. Crit. Rev. Oncol./Hematol., 2007, 61(3), 222-229. (Pubitemid 46329429)
159. Zentner, G.M.; Rathi, R.; Shih, C.; McRea, J.C.; Seo, M.H.; Oh, H.; Rhee, B.G.; Mestecky, J.; Moldoveanu, Z.; Morgan, M.; Weitman, S. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Release, 2001, 72(1-3), 203-215. (Pubitemid 32522358)
160. Rowinsky, E.K.; Eisenhauer, E.A.; Chaudhry, V.; Arbuck, S.G.; Donehower, R.C. Clinical toxicities encountered with paclitaxel (Taxol(R)). Semin. Oncol., 1993, 20(4), 1-15. (Pubitemid 23239390)
161. Marupudi, N.I.; Han, J.E.; Li, K.W.; Renard, V.M.; Tyler, B.M.; Brem, H. Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin. Drug Saf., 2007, 6(5), 609-621. (Pubitemid 351308218)
162. Spencer, C.M.; Faulds, D. Paclitaxel - A review of its pharma-codynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs, 1994, 48(5), 794-847. (Pubitemid 24304427)
163. Fiorica, F.; Di Bona, D.; Schepis, F.; Licata, A.; Shahied, L.; Venturi, A.; Falchi, A.M.; Craxi, A.; Camma, C. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut, 2004, 53(7), 925-930. (Pubitemid 38824146)
164. Elstad, N.L.; Fowers, K.D. OncoGel (ReGel/paclitaxel) - Clinical applications for a novel paclitaxel delivery system. Adv. Drug De-liv. Rev., 2009, 61(10), 785-794.
165. Singh, S.; Dash, A.K. Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges. Crit. Rev. Ther. Drug Carr. Syst., 2009, 26(4), 333-372.
166. Ostacolo, L.; Marra, M.; Ungaro, F.; Zappavigna, S.; Maglio, G.; Quaglia, F.; Abbruzzese, A.; Caraglia, M. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon- caprolactone) block copolymers: Do nanocarrier properties have a role? J. Control. Release, 2010, 148(2), 255-263.
167. Zhang, Y.A.; Wang, X.Q.; Wang, J.C.; Zhang, X.A.; Zhang, Q.A. Octreotide-Modified Polymeric Micelles as Potential Carriers for Targeted Docetaxel Delivery to Somatostatin Receptor Overex-pressing Tumor Cells. Pharm. Res., 2011, 28(5), 1167-1178.
168. Xing, Z.M.; Liu, Z.G.; Zu, Y.G.; Fu, Y.J.; Zhao, C.J.; Zhao, X.H.; Meng, R.H.; Tan, S.N. Synthesis of camptothecin-loaded gold nanomaterials. Appl. Surf. Sci., 2010, 256(12), 3917-3920.
169. Brannon-Peppas, L.; Blanchette, J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev., 2004, 56(11), 1649-1659. (Pubitemid 39177694)
170. Shen, Y.Q.; Tang, H.D.; Zhan, Y.H.; Van Kirk, E.A.; Murdoch, W.J. Degradable Poly(beta-amino ester) nanoparticles for cancer cytoplasmic drug delivery. Nanomed.-Nanotechnol. Biol. Med., 2009, 5(2), 192-201.
171. Ueki, K.; Onishi, H.; Sasatsu, M.; Machida, Y. Preparation of Car-boxy-PEG-PLA Nanoparticles Loaded With Camptothecin and Their Body Distribution in Solid Tumor-Bearing Mice. Drug Dev. Res., 2009, 70(7), 512-519.
172. Zhu, A.P.; Luo, X.D.; Dai, S. Chitosan-poly(acrylic acid) complex modified paramagnetic Fe3O4 nanoparticles for camptothecin loading and release. J. Mater. Res., 2009, 24(7), 2307-2315.
173. Huang, Z.R.; Hua, S.C.; Yang, Y.L.; Fang, J.Y. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin., 2008, 29(9), 1094-1102.
174. Koo, O.M.Y.; Rubinstein, I.; Oenyueksel, H. Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis. Pharm. Res., 2011, 28(4), 776-787.
175. Bisht, S.; Maitra, A. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdiscip. Rev.-Nanomed. Nano-biotechnol., 2009, 1(4), 415-425.
176. Kang, K.W.; Chun, M.K.; Kim, O.; Subedi, R.K.; Ahn, S.G.; Yoon, J.H.; Choi, H.K. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(2), 210-213.
177. Khdair, A.; Chen, D.; Patil, Y.; Ma, L.N.; Dou, Q.P.; Shekhar, M.P.V.; Panyam, J. Nano particle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. J. Control. Release, 2010, 141(2), 137-144.
178. Huska, D.; Adam, V.; Babula, P.; Hrabeta, J.; Stiborova, M.; Eckschlager, T.; Trnkova, L.; Kizek, R. Square-Wave Voltamme-try as a Tool for Investigation of Doxorubicin Interactions with DNA Isolated from Neuroblastoma Cells. Electroanalysis, 2009, 21(3-5), 487-494.
179. Manocha, B.; Margaritis, A. Controlled Release of Doxorubicin from Doxorubicin/gamma-Polyglutamic Acid Ionic Complex. J. Nanomater., 2010, Art. No. 780171(9.
180. Asadishad, B.; Vossoughi, M.; Alamzadeh, I. In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells. Biotechnol. Lett., 2010, 32(5), 649-654.
181. Yang, X.Y.; Chen, L.; Han, B.; Yang, X.L.; Duan, H.Q. Preparation of magnetite and tumor dual-targeting hollow polymer micro-spheres with pH-sensitivity for anticancer drug-carriers. Polymer, 2010, 51(12), 2533-2539.
182. Grange, C.; Geninatti-Crich, S.; Esposito, G.; Alberti, D.; Tei, L.; Bussolati, B.; Aime, S.; Camussi, G. Combined Delivery and Magnetic Resonance Imaging of Neural Cell Adhesion Molecule-Targeted Doxorubicin-Containing Liposomes in Experimentally Induced Kaposi's Sarcoma. Cancer Res., 2010, 70(6), 2180-2190.
183. Choubey, J.; Bajpai, A.K. Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. J. Mater. Sci.-Mater. Med., 2010, 21(5), 1573-1586.
184. Rai, S.; Paliwal, R.; Vyas, S.P. Doxorubicin Encapsulated Nano-carriers for Targeted Delivery to Estrogen Responsive Breast Cancer. J. Biomed. Nanotechnol., 2011, 7(1), 121-122.
185. Kang, Y.M.; Kim, G.H.; Il Kim, J.; Kim, D.Y.; Lee, B.N.; Yoon, S.M.; Kim, J.H.; Kim, M.S. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer. Biomaterials, 2011, 32(20), 4556-4564.
186. Wang, J.; Chen, B.A.; Chen, J.A.; Cai, X.H.; Xia, G.H.; Liu, R.; Chen, P.S.; Zhang, Y.; Wang, X.M. Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. Int. J. Nanomed., 2011, 6(203-211.
187. Li, J.Y.; Chen, C.; Wang, X.M.; Gu, Z.Z.; Chen, B.A. Novel Strategy to Fabricate PLA/Au Nanocomposites as an Efficient Drug Carrier for Human Leukemia Cells in Vitro. Nanoscale Res. Lett., 2011, 6(8.
188. Krizkova, S.; Adam, V.; Petrlova, J.; Zitka, O.; Stejskal, K.; Zehnalek, J.; Sures, B.; Trnkova, L.; Beklova, M.; Kizek, R. A suggestion of electrochemical biosensor for study of platinum(II)-DNA interactions. Electroanalysis, 2007, 19(2-3), 331-338.
189. Petrlova, J.; Potesil, D.; Zehnalek, J.; Sures, B.; Adam, V.; Trnkova, L.; Kizek, R. Cisplatin electrochemical biosensor. Elec-trochim. Acta, 2006, 51(24), 5169-5173. (Pubitemid 43927719)
190. Huska, D.; Fabrik, I.; Baloun, J.; Adam, V.; Masarik, M.; Hubalek, J.; Vasku, A.; Trnkova, L.; Horna, A.; Zeman, L.; Kizek, R. Study of Interactions between Metallothionein and Cisplatin by using Differential Pulse Voltammetry Brdicka's reaction and Quartz Crystal Microbalance. Sensors, 2009, 9(3), 1355-1369.
191. Rosenberg, B.; Vancamp, L.; Krigas, T. Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode. Nature, 1965, 205(4972), 698-699.
192. Huxford, R.C.; Della Rocca, J.; Lin, W.B. Metal-organic frameworks as potential drug carriers. Curr. Opin. Chem. Biol., 2010, 14(2), 262-268.
193. Rieter, W.J.; Pott, K.M.; Taylor, K.M.L.; Lin, W.B. Nanoscale coordination polymers for platinum-based anticancer drug delivery. J. Am. Chem. Soc., 2008, 130(35), 11584-+.
194. Jain, A.; Jain, S.K.; Ganesh, N.; Barve, J.; Beg, A.M. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(1), 179-190.
195. Tang, H.; Murphy, C.J.; Zhang, B.; Shen, Y.; Van Kirk, E.A.; Murdoch, W.J.; Radosz, M. Curcumin polymers as anticancer conjugates. Biomaterials, 2010, 31(27), 7139-7149.
196. Sahu, A.; Bora, U.; Kasoju, N.; Goswami, P. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomaterialia, 2008, 4(6), 1752-1761.
197. Das, R.K.; Kasoju, N.; Bora, U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(1), 153-160.
198. Kasoju, N.; Bora, D.K.; Bhonde, R.R.; Bora, U. Synthesis, characterization, and application of novel biodegradable self-assembled 2-(N-phthalimido) ethyl-palmitate nanoparticles for cancer therapy. J. Nanopart. Res., 2010, 12(3), 801-810.
199. Mohanty, C.; Das, M.; Kanwar, J.R.; Sahoo, S.K. Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy. Curr. Drug Deliv., 2011, 8(1), 45-58.
200. Fukuyo, Y.; Hunt, C.R.; Horikoshi, N. Geldanamycin and its anticancer activities. Cancer Letters, 2010, 290(1), 24-35.
201. Won, Y.W.; Yoon, S.M.; Sonn, C.H.; Lee, K.M.; Kim, Y.H. Nano Self-Assembly of Recombinant Human Gelatin Conjugated with alpha-Tocopheryl Succinate for Hsp90 Inhibitor, 17-AAG, Delivery. ACS Nano, 2011, 5(5), 3839-3848.
202. Sood, A.; Panchagnula, R. Peroral route: An opportunity for protein and peptide drug delivery. Chem. Rev., 2001, 101(11), 3275-3303. (Pubitemid 35373038)
203. Fernandes, C.A.; Vanbever, R. Preclinical models for pulmonary drug delivery. Expert Opin. Drug Deliv., 2009, 6(11), 1231-1245.
204. Chow, A.H.L.; Tong, H.H.Y.; Chattopadhyay, P.; Shekunov, B.Y. Particle engineering for pulmonary drug delivery. Pharm. Res., 2007, 24(3), 411-437. (Pubitemid 46295160)
205. Pilcer, G.; Amighi, K. Formulation strategy and use of excipients in pulmonary drug delivery. Int. J. Pharm., 2010, 392(1-2), 1-19.
206. Rytting, E.; Nguyen, J.; Wang, X.Y.; Kissel, T. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin. Drug Deliv., 2008, 5(6), 629-639. (Pubitemid 351998253)
207. Smola, M.; Vandamme, T.; Sokolowski, A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int. J. Nanomed., 2008, 3(1), 1-19. (Pubitemid 351517072)
208. Tolman, J.A.; Williams, R.O. Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on phar-macokinetic properties. Drug Dev. Ind. Pharm., 2010, 36(1), 1-30.
209. Barry, B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Biopharm., 2001, 14(2), 101-114. (Pubitemid 32737532)
210. Karande, P.; Mitragotri, S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim. Biophys. Acta-Biomembr., 2009, 1788(11), 2362-2373.
211. Prausnitz, M.R.; Langer, R. Transdermal drug delivery. Nat. Bio-technol., 2008, 26(11), 1261-1268.
212. Zhang, Q.; Grice, J.E.; Wang, G.J.; Roberts, M.S. Cutaneous Metabolism in Transdermal Drug Delivery. Curr. Drug Metab., 2009, 10(3), 227-235.
213. Gaucher, G.; Marchessault, R.H.; Leroux, J.C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release, 2010, 143(1), 2-12.
214. Joshi, M.D.; Muller, R.H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm., 2009, 71(2), 161-172.
215. Nguyen, D.N.; Green, J.J.; Chan, J.M.; Longer, R.; Anderson, D.G. Polymeric Materials for Gene Delivery and DNA Vaccination. Adv. Mater., 2009, 21(8), 847-867.
216. Slowing, II; Vivero-Escoto, J.L.; Wu, C.W.; Lin, V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev., 2008, 60(11), 1278-1288.
217. Wang, Z.; Chui, W.K.; Ho, P.C. Integrin targeted drug and gene delivery. Expert Opin. Drug Deliv., 2010, 7(2), 159-171.
218. Obata, Y.; Ciofani, G.; Raffa, V.; Cuschieri, A.; Menciassi, A.; Dario, P.; Takeoka, S. Evaluation of cationic liposomes composed of an amino acid-based lipid for neuronal transfection. Nanomed.-Nanotechnol. Biol. Med., 2010, 6(1), 70-77.
219. Ciofani, G.; Obata, Y.; Sato, I.; Okamura, Y.; Raffa, V.; Menciassi, A.; Dario, P.; Takeda, N.; Takeoka, S. Realization, characterization and functionalization of lipidic wrapped carbon nanotubes. J. Nanopart. Res., 2009, 11(2), 477-484.
220. Ciofani, G.; Raffa, V.; Yu, J.; Chen, Y.; Obata, Y.; Takeoka, S.; Menciassi, A.; Cuschieri, A. Boron Nitride Nanotubes: A Novel Vector for Targeted Magnetic Drug Delivery. Curr. Nanosci., 2009, 5(1), 33-38.